Author:
Villa Antoine,Tremolet Kevin,Martinez Béatrice,Petit Murielle,Dascon Xavier,Stanek Jérémie,Ducint Dominique,Titier-Debeaupuis Karine,Verdun-Esquer Catherine,Molimard Mathieu,Canal-Raffin Mireille
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference29 articles.
1. Molecular mechanism of action and pharmacokinetic properties of methotrexate;Maksimovic;Mol. Biol. Rep.,2020
2. FDA, Content and Format of Labeling for Human Prescription Drug and Biological Products ; Requirements for Pregnancy and Lactation Labeling, Food and Drug Administration, 2008.
3. FDA pregnancy risk categories and the CPS;Law;Can. Fam. Physician,2010
4. NIOSH, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2016.
5. An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial;Warren;Lancet,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献